Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Diagnostic procedures such as magnetic resonance imaging (MRI) using ferumoxytol
may improve the ability to detect cancer that has spread to the lymph nodes and may help plan
effective cancer treatment.
PURPOSE: This clinical trial is studying how well MRI using ferumoxytol works in detecting
metastases to the lymph nodes in patients with primary prostate cancer or primary breast
cancer.